Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Scienture Holdings (SCNX.US)$ Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
3 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
571 Views
Comment
Sign in to post a comment